INTEGRATED FILING — Other than Banks
General information about company
| Scrip code |
000000 |
| NSE Symbol |
CHANDAN |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE0B2N01016 |
| Name of Company |
Chandan Healthcare Limited |
| Type of company |
SME |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
29-05-2026 |
| Date on which prior intimation of the meeting for considering financial results was
informed to the exchange |
26-05-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Fourth quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Audited |
| Segment Reporting |
Single segment |
| Description of single segment |
Healthcare Sector |
| Start date and time of board meeting |
29-05-2026
17:00:00 |
| End date and time of board meeting |
29-05-2026 20:30:00
|
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results — Other than Bank
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Revenue From Operations |
|
Revenue from operations |
7,558.36 |
27,639.44 |
|
Other income |
182.36 |
427.85 |
|
Total Income |
7,740.72 |
28,067.29 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
605.12 |
2,286.65 |
| (b) |
Purchases of stock-in-trade |
2,815.48 |
11,359.87 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
54.17 |
(278.05) |
| (d) |
Employee benefit expense |
1,289.61 |
4,419.65 |
| (e) |
Finance costs |
180.22 |
588.19 |
| (f) |
Depreciation and amortisation expense
|
244.68 |
977.98 |
| (g) |
Other Expenses |
| 1 |
Other Expenses |
1,551.10 |
4,594.80 |
|
Total other expenses |
1,551.10 |
4,594.80 |
|
Total expenses |
6,740.38 |
23,949.09 |
| 3 |
Profit before exceptional and extraordinary items and tax |
1,000.34 |
4,118.20 |
| 4 |
Exceptional items |
(68.67) |
(291.54) |
| 5 |
Profit before extraordinary items and tax |
931.67 |
3,826.66 |
| 6 |
Extraordinary items |
0.00 |
0.00 |
| 7 |
Profit before tax |
931.67 |
3,826.66 |
| 8 |
Tax Expense |
|
|
Current tax |
227.31 |
934.31 |
|
Deferred tax |
2.98 |
36.99 |
|
Total tax expenses |
230.29 |
971.30 |
| 9 |
Net Profit Loss for the period from continuing operations |
701.38 |
2,855.36 |
| 10 |
Profit (loss) from discontinuing operations before tax |
0.00 |
0.00 |
| 11 |
Tax expense of discontinuing operations |
0.00 |
0.00 |
| 12 |
Net profit (loss) from discontinuing operation after tax |
0.00 |
0.00 |
| 13 |
Profit (loss) for period before minority interest |
701.38 |
2,855.36 |
| 14 |
Share of profit (loss) of associates |
0.00 |
0.00 |
| 15 |
Profit (loss) of minority interest |
(9.59) |
(149.62) |
| 16 |
Net profit (Loss) for the period |
691.79 |
2,705.74 |
| 17 |
Details of equity share capital |
|
Paid-up equity share capital |
2,445.21 |
2,445.21 |
|
Face value of equity share capital |
10 |
10 |
| 18 |
Reserves excluding revaluation reserve |
|
14,543.04 |
| 19 |
Earnings per equity share |
|
Basic earnings (loss) per share from continuing and discontinued operations
|
2.83 |
11.07 |
|
Diluted earnings (loss) per share from continuing and discontinued operations |
2.53 |
10.76 |
| 20 |
Debt equity ratio |
|
|
| 21 |
Debt service coverage ratio |
|
|
| 22 |
Interest service coverage ratio |
|
|
| 23 |
Disclosure of notes on financial results |
|
Remarks
Cash flow statement — indirect
Amount in (Lakhs)
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
| 1 |
Statement of cash flows |
|
Cash flows from used in operating activities |
|
Profit before extraordinary items and tax |
3,826.66 |
| 2 |
Adjustments for reconcile profit (loss) |
|
Adjustments to profit (loss) |
|
Adjustments for finance costs |
582.00 |
|
Adjustments for depreciation and amortisation expense |
977.98 |
|
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss
|
0.00
|
|
Adjustments for unrealised foreign exchange losses gains |
0.00 |
|
Adjustments for dividend income |
0.00 |
|
Adjustments for share-based payments |
0.00 |
|
Other adjustments for which cash effects are investing or financing cash flow |
(399.36) |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
166.49 |
|
Share of profit and loss from partnership firm or association of persons or limited
liability partnerships |
0.00
|
|
Total adjustments to profit (loss) |
1,327.11
|
| 3 |
Adjustments for working capital |
|
Adjustments for decrease (increase) in inventories |
(237.55) |
|
Adjustments for decrease (increase) in trade receivables |
(3,919.57) |
|
Adjustments for decrease (increase) in other current assets |
(556.47) |
|
Adjustments for increase (decrease) in trade payables |
1,496.06 |
|
Adjustments for increase (decrease) in other current liabilities |
652.50 |
|
Adjustments for provisions |
0.00 |
|
Total adjustments for working capital |
(2,565.03) |
|
Total adjustments for reconcile profit (loss) |
(1,237.92) |
|
Net cash flows from (used in) operations |
2,588.74 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
971.30 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in) operating activities before extraordinary
items |
1,617.44 |
|
Proceeds from extraordinary items |
0.00 |
|
Payment for extraordinary items |
0.00 |
|
Net cash flows from (used in) operating activities |
1,617.44 |
| 4 |
Cash flows from used in investing activities |
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities |
0.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of persons or limited
liability partnerships |
0.00
|
|
Cash payment for investment in partnership firm or association of persons or limited
liability partnerships |
0.00
|
|
Proceeds from sales of property plant and equipment |
0.00 |
|
Purchase of property plant and equipment |
4,255.51 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and swap contracts
|
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and swap contracts
|
0.00 |
|
Dividends received |
0.00 |
|
Interest received |
399.36 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
(133.48) |
|
Proceeds from government grants |
0.00 |
|
Net cash flows from (used in) investing activities before extraordinary items |
(3,989.63) |
|
Proceeds from extraordinary items |
0.00 |
|
Payment for extraordinary items |
0.00 |
|
Net cash flows from (used in) investing activities |
(3,989.63) |
|
Cash flows from used in financing activities |
|
Proceeds from issuing shares |
0.00 |
|
Proceeds from issuing other equity instruments |
2,133.46 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
558.23 |
|
Repayments of borrowings |
0.00 |
|
Dividends paid |
0.00 |
|
Interest paid |
0.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
(582.00) |
|
|
Net cash flows from (used in) financing activities before extraordinary items |
2,109.69
|
|
Proceeds from extraordinary items |
0.00 |
|
Payment for extraordinary items |
0.00 |
|
Net cash flows from (used in) financing activities |
2,109.69 |
|
Net increase (decrease) in cash and cash equivalents before effect of
exchange rate changes |
(262.50)
|
| 6 |
Effect of exchange rate changes on cash and cash equivalents |
|
Effect of exchange rate changes on cash and cash equivalents |
0.00 |
|
Net increase (decrease) in cash and cash equivalents |
(262.50) |
|
Cash and cash equivalents cash flow statement at beginning of period |
620.71 |
|
Cash and cash equivalents cash flow statement at end of period |
358.21 |
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
31-03-2026 |
| Whether results are audited or unaudited |
Audited |
| Nature of report standalone or consolidated |
Consolidated |
|
Equity and liabilities |
| 1 |
Shareholders' funds |
|
Share capital |
2,445.21 |
|
Reserves and surplus |
14,543.04 |
|
Money received against share warrants |
111.25 |
|
Total shareholders' funds |
17,099.50 |
| 2 |
Share application money pending allotment |
0.00 |
| 3 |
Deferred government grants |
0.00 |
| 4 |
Minority interest |
53020000 |
| 5 |
Non-current liabilities |
|
Long-term borrowings |
2,897.34 |
|
Deferred tax liabilities (net) |
235.54 |
|
Foreign currency monetary item translation difference liability account |
0.00 |
|
Other long-term liabilities |
|
| 1 |
Other long-term liabilities |
2.20 |
|
Total of Other long-term liabilities |
2.20 |
|
Long-term provisions |
460.48 |
|
Total non-current liabilities |
3,595.56 |
| 6 |
Current liabilities |
|
Short-term borrowings |
2,477.27 |
|
Trade Payables |
|
(A) Total outstanding dues of micro enterprises and small enterprises |
1,617.01 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
2,473.22 |
|
Total Trade payable |
4,090.23 |
|
Other current liabilities |
|
| 1 |
Other current liabilities |
1,052.10 |
|
Total of Other long-term liabilities |
1,052.10 |
|
Short-term provisions |
106.97 |
|
Total current liabilities |
7,726.57 |
|
Total equity and liabilities |
28,951.83 |
|
Assets |
|
| 1 |
Non-current assets |
|
| i |
Property, Plant and Equipment and Intangible assets
|
|
|
Property, Plant and Equipment |
9,680.81 |
|
Producing properties |
0.00 |
|
Intangible assets |
443.28 |
|
Preproducing properties |
0.00 |
|
Property, Plant and Equipment capital work-in-progress |
1,198.83 |
|
Intangible assets under development or work-in-progress |
0.00 |
|
Total Property, Plant and Equipment and Intangible assets |
11,322.92 |
| ii |
Non-current investments |
784.93 |
| v |
Deferred tax assets (net) |
26.27 |
| vi |
Foreign currency monetary item translation difference asset account |
0.00 |
| vii |
Long-term loans and advances |
100.00 |
|
Other non-current assets |
|
| 1 |
Other non-current assets |
246.75 |
|
Total of Other non-current assets |
246.75 |
|
Total non-current assets |
12,480.87 |
|
Current assets |
|
Current investments |
1,211.25 |
|
Inventories |
3,373.90 |
|
Trade receivables |
8,640.21 |
|
Cash and cash equivalents |
358.21 |
|
Bank balance other than cash and cash equivalents |
0.00 |
|
Short-term loans and advances |
1,763.12 |
|
Other current assets |
|
| 1 |
Other current assets |
1,124.27 |
|
Total of Other current assets |
1,124.27 |
|
Total current assets |
16,470.96 |
|
Total assets |
28,951.83 |
|
Disclosure of notes on assets and liabilities |
Textual Information(1) |
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company
results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| Whether results are audited or unaudited |
Audited |
Audited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
|
Total Segment Revenue |
|
|
|
Less: Inter segment revenue |
|
|
|
Revenue from operations |
|
|
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
|
Total Profit before tax |
|
|
|
i. Finance cost |
|
|
|
ii. Other Unallocable Expenditure net
off Unallocable income |
|
|
|
Profit before tax |
|
|
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
|
Total Segment Asset |
|
|
|
Un-allocable Assets |
|
|
|
Net Segment Asset |
|
|
| 4 |
Segment Liabilities |
|
Segment Liabilities |
|
Total Segment Liabilities |
|
|
|
Un-allocable Liabilities |
|
|
|
Net Segment Liabilities |
|
|
|
Disclosure of notes on segments |
|
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
MSNT & Associates LLP |
Yes |
31-01-2029 |